Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson’s disease models
出版年份 2015 全文链接
标题
Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson’s disease models
作者
关键词
-
出版物
BRAIN
Volume 138, Issue 5, Pages 1247-1262
出版商
Oxford University Press (OUP)
发表日期
2015-02-26
DOI
10.1093/brain/awv034
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Subpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseases
- (2014) Qingshan Wang et al. GLIA
- Macrophage Antigen Complex-1 Mediates Reactive Microgliosis and Progressive Dopaminergic Neurodegeneration in the MPTP Model of Parkinson's Disease
- (2014) X. Hu et al. JOURNAL OF IMMUNOLOGY
- Substance P Exacerbates Dopaminergic Neurodegeneration through Neurokinin-1 Receptor-Independent Activation of Microglial NADPH Oxidase
- (2014) Q. Wang et al. JOURNAL OF NEUROSCIENCE
- NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration
- (2013) Liya Qin et al. GLIA
- Subsite Awareness in Neuropathology Evaluation of National Toxicology Program (NTP) Studies
- (2013) Deepa B. Rao et al. TOXICOLOGIC PATHOLOGY
- Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
- (2013) Lars Brichta et al. TRENDS IN NEUROSCIENCES
- The immunology of neurodegeneration
- (2012) Eva Czirr et al. JOURNAL OF CLINICAL INVESTIGATION
- Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice
- (2012) Qingshan Wang et al. Journal of Neuroinflammation
- NADPH oxidases: novel therapeutic targets for neurodegenerative diseases
- (2012) Hui-Ming Gao et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease
- (2011) Hui-Ming Gao et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- NSAID use and risk of Parkinson disease: a population-based case-control study
- (2011) C. Becker et al. EUROPEAN JOURNAL OF NEUROLOGY
- HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive Neurodegeneration
- (2011) H.-M. Gao et al. JOURNAL OF NEUROSCIENCE
- Neurodegeneration and Inflammation in Parkinson's disease
- (2011) Sudarshan Phani et al. PARKINSONISM & RELATED DISORDERS
- Reactive microgliosis: extracellular μ-calpain and microglia-mediated dopaminergic neurotoxicity
- (2010) Shannon Levesque et al. BRAIN
- Microglia in neurodegenerative disease
- (2010) V. Hugh Perry et al. Nature Reviews Neurology
- Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease
- (2010) K. Xu et al. NEUROSCIENCE
- NSAID Use and the Risk of Parkinsonʼs Disease
- (2009) Ali Samii et al. DRUGS & AGING
- Neuroprotection trials in Parkinson's disease: Systematic review
- (2009) Robert G. Hart et al. MOVEMENT DISORDERS
- Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific
- (2008) Elisabetta Aldieri et al. CURRENT DRUG METABOLISM
- Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits
- (2008) Yuxin Liu et al. NEUROTOXICOLOGY
- NOX enzymes as novel targets for drug development
- (2008) J. David Lambeth et al. Seminars in Immunopathology
- Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
- (2008) Hui-Ming Gao et al. TRENDS IN IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started